You are here

Home

Clinical Trials: Heart Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, June 25, 2021 - 12:00
Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC)
Conditions:   Myocardial Ischemia;   Ventricular Dysfunction, Left
Intervention:   Biological: Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Monday, June 14, 2021 - 12:00
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial.
Condition:   Hypoplastic Left Heart Syndrome
Intervention:   Biological: Lomecel-B medicinal signaling cells
Sponsors:   Ann & Robert H Lurie Children's Hospital of Chicago;   National Heart, Lung, and Blood Institute (NHLBI);   The University of Texas Health Science Center, Houston;   Longeveron Inc.
Recruiting
Posted: Monday, June 14, 2021 - 12:00
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children
Condition:   Heart Transplantation
Intervention:   Biological: Autologous thyTreg
Sponsors:   Rafael Correa-Rocha;   Instituto de Salud Carlos III;   Fundación Familia Alonso
Recruiting
Posted: Friday, May 28, 2021 - 12:00
Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD
Condition:   Congenital Heart Disease, SRV Dependent
Intervention:   Biological: Autologous mononuclear cells
Sponsors:   Timothy J Nelson, MD, PhD;   Mayo Clinic;   University of Oklahoma;   Children's Hospital of Philadelphia;   Children's Hospital Los Angeles;   Children's Hospitals and Clinics of Minnesota;   Children's Hospital Colorado;   Ochsner Health System;   Children's of Alabama;   Children's Hospital Medical Center, Cincinnati;   The Hospital for Sick Children
Not yet recruiting
Posted: Thursday, May 27, 2021 - 12:00
PLIN1 Variants in Precocious ACS (SCAPLIN)
Condition:   Acute Coronary Syndrome
Intervention:   Genetic: PLIN1 gene sequencing
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting
Posted: Monday, March 1, 2021 - 12:00
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
Conditions:   Diabetes Mellitus;   Ischemic Heart Disease
Interventions:   Drug: 100 million Allogeneic Mesenchymal Human Stem Cells;   Other: Placebo
Sponsors:   Joshua M Hare;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Posted: Thursday, January 28, 2021 - 12:00
Heart Patch for Myocardial Infarction COVID-19
Conditions:   Myocardial Infarction;   Heart Diseases
Intervention:   Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
Sponsor:   Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Not yet recruiting
Posted: Tuesday, January 5, 2021 - 12:00
ADR-002K for Patients With Ischemic Cardiomyopathy Who Undergo Coronary Artery Bypass Surgery
Condition:   D017202
Intervention:   Biological: ADR-002K administration
Sponsors:   Osaka University;   Rohto Pharmaceutical Co., Ltd.
Recruiting
Posted: Friday, October 9, 2020 - 12:00
Mutation-specific Therapy for the Long QT Syndrome
Condition:   Long QT Syndrome
Intervention:   Drug: Lumacaftor / Ivacaftor, Orkambi® Oral Tablet
Sponsor:   Istituto Auxologico Italiano
Not yet recruiting
Posted: Wednesday, September 16, 2020 - 12:00
WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Interventions:   Biological: Intravenous infusion placebo;   Biological: Intravenous infusion WJMSCs
Sponsors:   Navy General Hospital, Beijing;   Peking University Third Hospital;   Peking Union Medical College Hospital;   Xijing Hospital;   Chinese PLA General Hospital
Not yet recruiting

Pages